Alerts11.14.23

HHS-HRSA Terminates 340B Drug Pricing Program Registration Waiver

HHS-HRSA Terminates 340B Drug Pricing Program Registration Waiver

The HHS-HRSA issued a notice terminating its 340B Program registration waiver for hospitals’ offsite, outpatient facilities

The Health Resources and Services Administration of the U.S. Department of Health and Human Services (HHS-HRSA) issued a notice to safety net hospitals on Oct. 27 that ends the 340B offsite, outpatient hospital facility registration waiver that went into effect during the COVID-19 pandemic.

Keep Up to Date in a Changing World

Do you want to receive more valuable insights directly in your inbox? Visit our subscription center and let us know what you’re interested in learning more about.
Subscription Banner